Logo image of LIDR

AEYE INC (LIDR) Stock Fundamental Analysis

USA - NASDAQ:LIDR - US0081832042 - Common Stock

2.8136 USD
+0.26 (+10.34%)
Last: 10/6/2025, 3:21:08 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LIDR. LIDR was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of LIDR have multiple concerns. LIDR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LIDR had negative earnings in the past year.
LIDR had a negative operating cash flow in the past year.
LIDR had negative earnings in each of the past 5 years.
In the past 5 years LIDR always reported negative operating cash flow.
LIDR Yearly Net Income VS EBIT VS OCF VS FCFLIDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -156.28%, LIDR is doing worse than 94.35% of the companies in the same industry.
LIDR has a worse Return On Equity (-339.23%) than 92.74% of its industry peers.
Industry RankSector Rank
ROA -156.28%
ROE -339.23%
ROIC N/A
ROA(3y)-121.73%
ROA(5y)-100.53%
ROE(3y)-213.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIDR Yearly ROA, ROE, ROICLIDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

LIDR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LIDR Yearly Profit, Operating, Gross MarginsLIDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

3

2. Health

2.1 Basic Checks

LIDR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LIDR has been increased compared to 1 year ago.
LIDR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, LIDR has a worse debt to assets ratio.
LIDR Yearly Shares OutstandingLIDR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
LIDR Yearly Total Debt VS Total AssetsLIDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -23.96, we must say that LIDR is in the distress zone and has some risk of bankruptcy.
LIDR has a worse Altman-Z score (-23.96) than 95.97% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that LIDR is not too dependend on debt financing.
LIDR has a Debt to Equity ratio (0.21) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z -23.96
ROIC/WACCN/A
WACC9.11%
LIDR Yearly LT Debt VS Equity VS FCFLIDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.93 indicates that LIDR should not have too much problems paying its short term obligations.
LIDR has a Current ratio of 1.93. This is in the lower half of the industry: LIDR underperforms 62.10% of its industry peers.
LIDR has a Quick Ratio of 1.91. This is a normal value and indicates that LIDR is financially healthy and should not expect problems in meeting its short term obligations.
LIDR has a better Quick ratio (1.91) than 60.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.91
LIDR Yearly Current Assets VS Current LiabilitesLIDR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

LIDR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.39%, which is quite impressive.
The Revenue for LIDR has decreased by -23.62% in the past year. This is quite bad
LIDR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -32.76% yearly.
EPS 1Y (TTM)55.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
Revenue 1Y (TTM)-23.62%
Revenue growth 3Y-59.36%
Revenue growth 5Y-32.76%
Sales Q2Q%-37.5%

3.2 Future

LIDR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.18% yearly.
LIDR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 403.94% yearly.
EPS Next Y68.92%
EPS Next 2Y33.97%
EPS Next 3Y22%
EPS Next 5Y22.18%
Revenue Next Year0.5%
Revenue Next 2Y440.43%
Revenue Next 3Y459.34%
Revenue Next 5Y403.94%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LIDR Yearly Revenue VS EstimatesLIDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
LIDR Yearly EPS VS EstimatesLIDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -5 -10 -15 -20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LIDR. In the last year negative earnings were reported.
Also next year LIDR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LIDR Price Earnings VS Forward Price EarningsLIDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIDR Per share dataLIDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

LIDR's earnings are expected to grow with 22.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.97%
EPS Next 3Y22%

More info and screens

0

5. Dividend

5.1 Amount

LIDR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AEYE INC

NASDAQ:LIDR (10/6/2025, 3:21:08 PM)

2.8136

+0.26 (+10.34%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners2.82%
Inst Owner Change0%
Ins Owners2.59%
Ins Owner Change0.02%
Market Cap112.38M
Analysts82.86
Price Target6.12 (117.51%)
Short Float %9.88%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.87%
Min EPS beat(2)70.92%
Max EPS beat(2)72.81%
EPS beat(4)4
Avg EPS beat(4)47.44%
Min EPS beat(4)22.89%
Max EPS beat(4)72.81%
EPS beat(8)8
Avg EPS beat(8)32.77%
EPS beat(12)12
Avg EPS beat(12)27.25%
EPS beat(16)12
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-96.3%
Min Revenue beat(2)-98.49%
Max Revenue beat(2)-94.12%
Revenue beat(4)1
Avg Revenue beat(4)-60.41%
Min Revenue beat(4)-98.49%
Max Revenue beat(4)1.96%
Revenue beat(8)1
Avg Revenue beat(8)-61.54%
Revenue beat(12)4
Avg Revenue beat(12)-40.66%
Revenue beat(16)6
Avg Revenue beat(16)-21.54%
PT rev (1m)500%
PT rev (3m)500%
EPS NQ rev (1m)79.74%
EPS NQ rev (3m)79.74%
EPS NY rev (1m)72.72%
EPS NY rev (3m)72.72%
Revenue NQ rev (1m)-97.67%
Revenue NQ rev (3m)-97.67%
Revenue NY rev (1m)-96.35%
Revenue NY rev (3m)-96.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 476.17
P/FCF N/A
P/OCF N/A
P/B 11.04
P/tB 11.04
EV/EBITDA N/A
EPS(TTM)-2.07
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS0.01
BVpS0.25
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -156.28%
ROE -339.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-121.73%
ROA(5y)-100.53%
ROE(3y)-213.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 179.73%
Cap/Sales 112.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.93
Quick Ratio 1.91
Altman-Z -23.96
F-Score3
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)266.21%
Cap/Depr(5y)267.75%
Cap/Sales(3y)162.98%
Cap/Sales(5y)155.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
EPS Next Y68.92%
EPS Next 2Y33.97%
EPS Next 3Y22%
EPS Next 5Y22.18%
Revenue 1Y (TTM)-23.62%
Revenue growth 3Y-59.36%
Revenue growth 5Y-32.76%
Sales Q2Q%-37.5%
Revenue Next Year0.5%
Revenue Next 2Y440.43%
Revenue Next 3Y459.34%
Revenue Next 5Y403.94%
EBIT growth 1Y39.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-16.44%
EBIT Next 3Y-1.65%
EBIT Next 5YN/A
FCF growth 1Y63.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.62%
OCF growth 3YN/A
OCF growth 5YN/A